The White House Has Rejected a Controversial Way to Fight High Drug Prices

fortune_magazine_logo1

It involves breaking patents on therapies.

The Obama Administration is reportedly pushing back on a controversial request by House Democrats to facilitate broader use of so-called march-in rights to nix drug patents as a way to fight steep medication price increases.

The Hill reports that Department of Health and Human Services Secretary Sylvia Burwell responded to a January letter from Rep. Lloyd Doggett (D-Texas) and more than 50 of his fellow Democrats by asserting that the existing criteria on march-in rights “are sufficiently clear” and that adding more regulatory guidance which targets drug prices “is not needed.”

***

Source: The White House Has Rejected a Controversial Way to Fight High Drug Prices
Picture: Simon Dawson – Bloomberg via Getty Images
Advertisements